Tong Ren Tang Chinese Medicine reported unaudited consolidated earnings results for the first quarter ended March 31, 2018. For the quarter, revenue was HKD 379,361,000 against HKD 315,029,000 a year ago. Operating profit was HKD 192,512,000 against HKD 167,528,000 a year ago. Profit before tax was HKD 195,780,000 against HKD 170,241,000 a year ago. Profit for the period was HKD 164,711,000 against HKD 137,501,000 a year ago. Profit attributable to owners of the parent was HKD 158,785,000 against HKD 132,554,000 a year ago. Basic and diluted EPS attributable to owners of the company was HKD 0.19 against HKD 0.16 a year ago.